{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:50:50Z","timestamp":1782201050331,"version":"3.54.5"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"DOI":"10.7759\/cureus.111338","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:39:56Z","timestamp":1782200396000},"source":"Crossref","is-referenced-by-count":0,"title":["Early Detection of Anthracycline-Induced Cardiomyopathy: A Narrative Review of the Role of Artificial Intelligence and Remote Monitoring"],"prefix":"10.7759","author":[{"given":"Tosin  T","family":"Fakiyesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi","family":"Olalude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaoluwa","family":"Adeyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olorungbami","family":"Anifalaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mmaduabuchi","family":"Ozioko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwapelumi","family":"Ogunseye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibukunoluwa","family":"Adedoyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiodun","family":"Adegbesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeolu A","family":"Badejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202000131","article-title":"Antitumour anthracyclines: progress and perspectives","volume":"15","author":"Martins-Teixeira MB","year":"2020","unstructured":"Martins-Teixeira MB, Carvalho I. Antitumour anthracyclines: progress and perspectives. ChemMedChem. 2020, 15:933-48. 10.1002\/cmdc.202000131","journal-title":"ChemMedChem"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20190653","article-title":"Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms","volume":"134","author":"Dadson K","year":"2020","unstructured":"Dadson K, Calvillo-Arg\u00fcelles O, Thavendiranathan P, Billia F. Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms. Clin Sci (Lond). 2020, 134:1859-85. 10.1042\/CS20190653","journal-title":"Clin Sci (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.02.019","article-title":"Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?","volume":"185","author":"Dempke WC","year":"2023","unstructured":"Dempke WC, Zielinski R, Winkler C, Silberman S, Reuther S, Priebe W. Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?. Eur J Cancer. 2023, 185:94-104. 10.1016\/j.ejca.2023.02.019","journal-title":"Eur J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.829553","article-title":"Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data","volume":"9","author":"Kwan JM","year":"2022","unstructured":"Kwan JM, Oikonomou EK, Henry ML, Sinusas AJ. Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data. Front Cardiovasc Med. 2022, 9:829553. 10.3389\/fcvm.2022.829553","journal-title":"Front Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55869","article-title":"Early diagnosis of cardiovascular diseases in the era of artificial intelligence: an in-depth review","volume":"16","author":"Almansouri NE","year":"2024","unstructured":"Almansouri NE, Awe M, Rajavelu S, et al.. Early diagnosis of cardiovascular diseases in the era of artificial intelligence: an in-depth review. Cureus. 2024, 16:e55869. 10.7759\/cureus.55869","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.11.004","article-title":"Machine learning identifies clinical and genetic factors associated with anthracycline cardiotoxicity in pediatric cancer survivors","volume":"2","author":"Chaix MA","year":"2020","unstructured":"Chaix MA, Parmar N, Kinnear C, et al.. Machine learning identifies clinical and genetic factors associated with anthracycline cardiotoxicity in pediatric cancer survivors. JACC CardioOncol. 2020, 2:690-706. 10.1016\/j.jaccao.2020.11.004","journal-title":"JACC CardioOncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45733-x","article-title":"Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms","volume":"15","author":"Yagi R","year":"2024","unstructured":"Yagi R, Goto S, Himeno Y, Katsumata Y, Hashimoto M, MacRae CA, Deo RC. Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms. Nat Commun. 2024, 15:2536. 10.1038\/s41467-024-45733-x","journal-title":"Nat Commun"},{"key":"ref8","article-title":"Innovations in Cardio-Oncology: Artificial Intelligence, Digital Health, and Precision Medicine","author":"Brown SA","year":"2025","unstructured":"Brown SA. Innovations in Cardio-Oncology: Artificial Intelligence, Digital Health, and Precision Medicine. Brown SA (ed): Elsevier, Amsterdam, Netherlands; 2025."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2021.02.017","article-title":"Arrhythmias and device therapies in patients with cancer therapy-induced cardiomyopathy","volume":"18","author":"Lee C","year":"2021","unstructured":"Lee C, Maan A, Singh JP, Fradley MG. Arrhythmias and device therapies in patients with cancer therapy-induced cardiomyopathy. Heart Rhythm. 2021, 18:1223-9. 10.1016\/j.hrthm.2021.02.017","journal-title":"Heart Rhythm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.07.016","article-title":"Anthracycline cardiotoxicity in adult cancer patients: JACC: CardioOncology state-of-the-art review","volume":"6","author":"Camilli M","year":"2024","unstructured":"Camilli M, Cipolla CM, Dent S, Minotti G, Cardinale DM. Anthracycline cardiotoxicity in adult cancer patients: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 2024, 6:655-77. 10.1016\/j.jaccao.2024.07.016","journal-title":"JACC CardioOncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1406247","article-title":"An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity","volume":"15","author":"Xie S","year":"2024","unstructured":"Xie S, Sun Y, Zhao X, et al.. An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity. Front Pharmacol. 2024, 15:1406247. 10.3389\/fphar.2024.1406247","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8863789","article-title":"Role of oxidative stress in the mechanisms of anthracycline-induced cardiotoxicity: effects of preventive strategies","volume":"2021","author":"Carrasco R","year":"2021","unstructured":"Carrasco R, Castillo RL, Gormaz JG, Carrillo M, Thavendiranathan P. Role of oxidative stress in the mechanisms of anthracycline-induced cardiotoxicity: effects of preventive strategies. Oxid Med Cell Longev. 2021, 2021:8863789. 10.1155\/2021\/8863789","journal-title":"Oxid Med Cell Longev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.201","article-title":"Topoisomerase 2\u03b2: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity","volume":"95","author":"Vejpongsa P","year":"2014","unstructured":"Vejpongsa P, Yeh ET. Topoisomerase 2\u03b2: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity. Clin Pharmacol Ther. 2014, 95:45-52. 10.1038\/clpt.2013.201","journal-title":"Clin Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/srep44735","article-title":"Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes","volume":"7","author":"Zhao L","year":"2017","unstructured":"Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017, 7:44735. 10.1038\/srep44735","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)","volume":"43","author":"Lyon AR","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, et al.. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J. 2022, 43:4229-361. 10.1093\/eurheartj\/ehac244","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2024.08.045","article-title":"Cardio-oncology and heart failure: a scientific statement from the Heart Failure Society of America","volume":"31","author":"Bloom MW","year":"2025","unstructured":"Bloom MW, Vo JB, Rodgers JE, et al.. Cardio-oncology and heart failure: a scientific statement from the Heart Failure Society of America. J Card Fail. 2025, 31:415-55. 10.1016\/j.cardfail.2024.08.045","journal-title":"J Card Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian SH","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, et al.. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2017, 35:893-911. 10.1200\/JCO.2016.70.5400","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt B","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, et al.. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016, 134:e579-646. 10.1161\/CIR.0000000000000455","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian SH","year":"2015","unstructured":"Armenian SH, Hudson MM, Mulder RL, et al.. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015, 16:e123-36. 10.1016\/S1470-2045(14)70409-7","journal-title":"Lancet Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001308","article-title":"Cardiovascular toxicity in patients treated for childhood cancer: a scientific statement from the American Heart Association","volume":"151","author":"Ryan TD","year":"2025","unstructured":"Ryan TD, Bates JE, Kinahan KE, et al.. Cardiovascular toxicity in patients treated for childhood cancer: a scientific statement from the American Heart Association. Circulation. 2025, 151:e926-43. 10.1161\/CIR.0000000000001308","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf118","article-title":"Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review","volume":"13","author":"Kremer LC","year":"2002","unstructured":"Kremer LC, van Dalen EC, Offringa M, Vo\u00fbte PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol. 2002, 13:503-12. 10.1093\/annonc\/mdf118","journal-title":"Ann Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002843","article-title":"Cancer therapy-related cardiac dysfunction and heart failure: part 2: prevention, treatment, guidelines, and future directions","volume":"9","author":"Hamo CE","year":"2016","unstructured":"Hamo CE, Bloom MW, Cardinale D, et al.. Cancer therapy-related cardiac dysfunction and heart failure: part 2: prevention, treatment, guidelines, and future directions. Circ Heart Fail. 2016, 9:e002843. 10.1161\/CIRCHEARTFAILURE.115.002843","journal-title":"Circ Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale D","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, et al.. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015, 131:1981-8. 10.1161\/CIRCULATIONAHA.114.013777","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002661","article-title":"Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging","volume":"9","author":"Bloom MW","year":"2016","unstructured":"Bloom MW, Hamo CE, Cardinale D, et al.. Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging. Circ Heart Fail. 2016, 9:e002661. 10.1161\/CIRCHEARTFAILURE.115.002661","journal-title":"Circ Heart Fail"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193225","article-title":"Cancer-induced cardiac dysfunction: mechanisms, diagnostics, and emerging therapeutics in the era of onco-cardiology","volume":"17","author":"Saha S","year":"2025","unstructured":"Saha S, Singh PK, Roy P, Vemuri V, Ratajczak MZ, Singh M, Kakar SS. Cancer-induced cardiac dysfunction: mechanisms, diagnostics, and emerging therapeutics in the era of onco-cardiology. Cancers (Basel). 2025, 17:3225. 10.3390\/cancers17193225","journal-title":"Cancers (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1631","article-title":"Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis","volume":"22","author":"Michel L","year":"2020","unstructured":"Michel L, Mincu RI, Mahabadi AA, Settelmeier S, Al-Rashid F, Rassaf T, Totzeck M. Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis. Eur J Heart Fail. 2020, 22:350-61. 10.1002\/ejhf.1631","journal-title":"Eur J Heart Fail"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-020-09968-2","article-title":"Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment","volume":"26","author":"Saleh Y","year":"2021","unstructured":"Saleh Y, Abdelkarim O, Herzallah K, Abela GS. Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment. Heart Fail Rev. 2021, 26:1159-73. 10.1007\/s10741-020-09968-2","journal-title":"Heart Fail Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-003-0615-3","article-title":"Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies","volume":"82","author":"Auner HW","year":"2003","unstructured":"Auner HW, Tinchon C, Linkesch W, Tiran A, Quehenberger F, Link H, Sill H. Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies. Ann Hematol. 2003, 82:218-22. 10.1007\/s00277-003-0615-3","journal-title":"Ann Hematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya H","year":"2012","unstructured":"Sawaya H, Sebag IA, Plana JC, et al.. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012, 5:596-603. 10.1161\/CIRCIMAGING.112.973321","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4424","article-title":"Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity","volume":"11","author":"Wang YD","year":"2016","unstructured":"Wang YD, Chen SX, Ren LQ. Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity. Oncol Lett. 2016, 11:3483-92. 10.3892\/ol.2016.4424","journal-title":"Oncol Lett"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.06.030","article-title":"Differences in natriuretic peptide levels by race\/ethnicity (from the Multi-Ethnic Study of Atherosclerosis)","volume":"120","author":"Gupta DK","year":"2017","unstructured":"Gupta DK, Daniels LB, Cheng S, et al.. Differences in natriuretic peptide levels by race\/ethnicity (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2017, 120:1008-15. 10.1016\/j.amjcard.2017.06.030","journal-title":"Am J Cardiol"},{"key":"ref32","unstructured":"Common terminology criteria for adverse events (CTCAE) v6.0 (MedDRA 28.0). (2025). Accessed. June 22, 2026: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v6.pdf."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020290","article-title":"Echocardiography monitoring during anthracycline administration in Hodgkin and non-Hodgkin\u2019s lymphoma: the TEI index evaluation","volume":"12","author":"Puzzovivo A","year":"2022","unstructured":"Puzzovivo A, Fioretti AM, Minoia C, et al.. Echocardiography monitoring during anthracycline administration in Hodgkin and non-Hodgkin\u2019s lymphoma: the TEI index evaluation. J Pers Med. 2022, 12:290. 10.3390\/jpm12020290","journal-title":"J Pers Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana JC","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, et al.. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014, 27:911-39. 10.1016\/j.echo.2014.07.012","journal-title":"J Am Soc Echocardiogr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.903719","article-title":"Cardiac MRI assessment of anthracycline-induced cardiotoxicity","volume":"9","author":"Mabudian L","year":"2022","unstructured":"Mabudian L, Jordan JH, Bottinor W, Hundley WG. Cardiac MRI assessment of anthracycline-induced cardiotoxicity. Front Cardiovasc Med. 2022, 9:903719. 10.3389\/fcvm.2022.903719","journal-title":"Front Cardiovasc Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/CP9.0000000000000142","article-title":"Advancing cardio-oncology: precision-guided cardiovascular care for oncology patients","volume":"10","author":"Liu JE","year":"2025","unstructured":"Liu JE. Advancing cardio-oncology: precision-guided cardiovascular care for oncology patients. Cardiol Plus. 2025, 10:241-5. 10.1097\/CP9.0000000000000142","journal-title":"Cardiol Plus"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac087","article-title":"Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction","volume":"119","author":"Tonry C","year":"2023","unstructured":"Tonry C, Russell-Hallinan A, McCune C, Collier P, Harbinson M, Dixon L, Watson CJ. Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction. Cardiovasc Res. 2023, 119:710-28. 10.1093\/cvr\/cvac087","journal-title":"Cardiovasc Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13060951","article-title":"A review of the role of artificial intelligence in healthcare","volume":"13","author":"Al Kuwaiti A","year":"2023","unstructured":"Al Kuwaiti A, Nazer K, Al-Reedy A, et al.. A review of the role of artificial intelligence in healthcare. J Pers Med. 2023, 13:951. 10.3390\/jpm13060951","journal-title":"J Pers Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s10559-022-00466-x","article-title":"Intelligent decision-support system for epidemiological diagnostics. I. A concept of architecture design","volume":"58","author":"Bazilevych KO","year":"2022","unstructured":"Bazilevych KO, Chumachenko DI, Hulianytskyi LF, Meniailov IS, Yakovlev SV. Intelligent decision-support system for epidemiological diagnostics. I. A concept of architecture design. Cybern Syst Anal. 2022, 58:343-53. 10.1007\/s10559-022-00466-x","journal-title":"Cybern Syst Anal"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-024-02062-1","article-title":"Artificial intelligence interpretation of the electrocardiogram: a state-of-the-art review","volume":"26","author":"Ose B","year":"2024","unstructured":"Ose B, Sattar Z, Gupta A, Toquica C, Harvey C, Noheria A. Artificial intelligence interpretation of the electrocardiogram: a state-of-the-art review. Curr Cardiol Rep. 2024, 26:561-80. 10.1007\/s11886-024-02062-1","journal-title":"Curr Cardiol Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/info14120665","article-title":"Revolutionizing vaccine development for COVID-19: a review of AI-based approaches","volume":"14","author":"Ghosh A","year":"2023","unstructured":"Ghosh A, Larrondo-Petrie MM, Pavlovic M. Revolutionizing vaccine development for COVID-19: a review of AI-based approaches. Information. 2023, 14:665. 10.3390\/info14120665","journal-title":"Information"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030406","article-title":"Predicting the onset of diabetes with machine learning methods","volume":"13","author":"Chou CY","year":"2023","unstructured":"Chou CY, Hsu DY, Chou CH. Predicting the onset of diabetes with machine learning methods. J Pers Med. 2023, 13:406. 10.3390\/jpm13030406","journal-title":"J Pers Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwad348","article-title":"Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy","volume":"31","author":"Jacobs JE","year":"2024","unstructured":"Jacobs JE, Greason G, Mangold KE, et al.. Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy. Eur J Prev Cardiol. 2024, 31:560-6. 10.1093\/eurjpc\/zwad348","journal-title":"Eur J Prev Cardiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.820263","article-title":"Novel surrogate markers of cardiovascular risk in the setting of autoimmune rheumatic diseases: current data and implications for the future","volume":"9","author":"Mandel A","year":"2022","unstructured":"Mandel A, Schwarting A, Cavagna L, Triantafyllias K. Novel surrogate markers of cardiovascular risk in the setting of autoimmune rheumatic diseases: current data and implications for the future. Front Med (Lausanne). 2022, 9:820263. 10.3389\/fmed.2022.820263","journal-title":"Front Med (Lausanne)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.70749\/ijbr.v3i5.1263","article-title":"Artificial intelligence in detecting subclinical cardiovascular disease: a new frontier in preventive cardiology","volume":"3","author":"Rehman AU","year":"2025","unstructured":"Rehman AU, Ullah F, Khan RD, Mahmood I, Khan A, Khan K. Artificial intelligence in detecting subclinical cardiovascular disease: a new frontier in preventive cardiology. Indus Journal of Bioscience Research. 2025, 3:198-203. 10.70749\/ijbr.v3i5.1263","journal-title":"Indus Journal of Bioscience Research"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-024-03256-y","article-title":"Artificial intelligence-enhanced detection of subclinical coronary artery disease in athletes: diagnostic performance and limitations","volume":"40","author":"K\u00fcbler J","year":"2024","unstructured":"K\u00fcbler J, Brendel JM, K\u00fcstner T, et al.. Artificial intelligence-enhanced detection of subclinical coronary artery disease in athletes: diagnostic performance and limitations. Int J Cardiovasc Imaging. 2024, 40:2503-11. 10.1007\/s10554-024-03256-y","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071557","article-title":"Designing an interpretability-based model to explain the artificial intelligence algorithms in healthcare","volume":"12","author":"Ennab M","year":"2022","unstructured":"Ennab M, Mcheick H. Designing an interpretability-based model to explain the artificial intelligence algorithms in healthcare. Diagnostics (Basel). 2022, 12:1557. 10.3390\/diagnostics12071557","journal-title":"Diagnostics (Basel)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17431-x","article-title":"Explainable artificial intelligence model to predict acute critical illness from electronic health records","volume":"11","author":"Lauritsen SM","year":"2020","unstructured":"Lauritsen SM, Kristensen M, Olsen MV, et al.. Explainable artificial intelligence model to predict acute critical illness from electronic health records. Nat Commun. 2020, 11:3852. 10.1038\/s41467-020-17431-x","journal-title":"Nat Commun"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.71486","article-title":"Wearable technology and its potential role in cardiovascular health monitoring and disease management","volume":"8","author":"Nazir A","year":"2025","unstructured":"Nazir A, Nazir A, Shah Wali Jamal M, et al.. Wearable technology and its potential role in cardiovascular health monitoring and disease management. Health Sci Rep. 2025, 8:e71486. 10.1002\/hsr2.71486","journal-title":"Health Sci Rep"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.01.046","article-title":"Wearable devices for ambulatory cardiac monitoring: JACC state-of-the-art review","volume":"75","author":"Sana F","year":"2020","unstructured":"Sana F, Isselbacher EM, Singh JP, Heist EK, Pathik B, Armoundas AA. Wearable devices for ambulatory cardiac monitoring: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:1582-92. 10.1016\/j.jacc.2020.01.046","journal-title":"J Am Coll Cardiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000875","article-title":"Wearable devices for hemodynamic assessment in cardiovascular disease: a short literature review","volume":"0","author":"Singh J","year":"2025","unstructured":"Singh J, Ellingson CJ, Gagarinova M, et al.. Wearable devices for hemodynamic assessment in cardiovascular disease: a short literature review. Cardiol Rev. 2025, 0:0. 10.1097\/CRD.0000000000000875","journal-title":"Cardiol Rev"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/23.022","article-title":"Benefits and challenges of remote patient monitoring as perceived by health care practitioners: a systematic review","volume":"27","author":"Serrano LP","year":"2023","unstructured":"Serrano LP, Maita KC, Avila FR, et al.. Benefits and challenges of remote patient monitoring as perceived by health care practitioners: a systematic review. Perm J. 2023, 27:100-11. 10.7812\/TPP\/23.022","journal-title":"Perm J"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol EJ","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019, 25:44-56. 10.1038\/s41591-018-0300-7","journal-title":"Nat Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz778","article-title":"Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics","volume":"41","author":"Boden WE","year":"2020","unstructured":"Boden WE, Bhatt DL, Toth PP, Ray KK, Chapman MJ, L\u00fcscher TF. Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics. Eur Heart J. 2020, 41:2304-12. 10.1093\/eurheartj\/ehz778","journal-title":"Eur Heart J"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz056","article-title":"Deep learning for cardiovascular medicine: a practical primer","volume":"40","author":"Krittanawong C","year":"2019","unstructured":"Krittanawong C, Johnson KW, Rosenson RS, et al.. Deep learning for cardiovascular medicine: a practical primer. Eur Heart J. 2019, 40:2058-73. 10.1093\/eurheartj\/ehz056","journal-title":"Eur Heart J"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1097\/HMR.0000000000000039","article-title":"Effective implementation of health information technologies in U.S. hospitals","volume":"41","author":"Khatri N","year":"2016","unstructured":"Khatri N, Gupta V. Effective implementation of health information technologies in U.S. hospitals. Health Care Manage Rev. 2016, 41:11-21. 10.1097\/HMR.0000000000000039","journal-title":"Health Care Manage Rev"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1145\/3706598.3714272","article-title":"CardioAI: a multimodal AI-based system to support symptom monitoring and risk prediction of cancer treatment-induced cardiotoxicity","author":"Wu S","year":"2025","unstructured":"Wu S, Cao W, Fu S, et al.. CardioAI: a multimodal AI-based system to support symptom monitoring and risk prediction of cancer treatment-induced cardiotoxicity. CHI '25: Proceedings of the 2025 CHI Conference on Human Factors in Computing Systems. Yamashita N, Evers V, Yatani K, Ding X, Lee B, Chetty M, Toups-Dugas P (ed): Association for Computing Machinery, Yokohama, Japan; 2025. 1-22. 10.1145\/3706598.3714272"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooad061","article-title":"Toward alert triage: scalable qualitative coding framework for analyzing alert notes from the Telehealth Intervention Program for Seniors (TIPS)","volume":"6","author":"Nguyen P","year":"2023","unstructured":"Nguyen P, Schiaffino MK, Zhang Z, Choi HW, Huh-Yoo J. Toward alert triage: scalable qualitative coding framework for analyzing alert notes from the Telehealth Intervention Program for Seniors (TIPS). JAMIA Open. 2023, 6:ooad061. 10.1093\/jamiaopen\/ooad061","journal-title":"JAMIA Open"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1145\/3544548.3581015","article-title":"Are two heads better than one in AI-assisted decision making? Comparing the behavior and performance of groups and individuals in human-AI collaborative recidivism risk assessment","author":"Chiang CW","year":"2023","unstructured":"Chiang CW, Lu Z, Li Z, Yin M. Are two heads better than one in AI-assisted decision making? Comparing the behavior and performance of groups and individuals in human-AI collaborative recidivism risk assessment. CHI '23: Proceedings of the 2023 CHI Conference on Human Factors in Computing Systems. Schmidt A, V\u00e4\u00e4n\u00e4nen K, Goyal T, et al. (ed): Association for Computing Machinery, Hamburg, DE; 2023. 1-18. 10.1145\/3544548.3581015"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3389\/fcomp.2023.1187299","article-title":"Human-centered design and evaluation of AI-empowered clinical decision support systems: a systematic review","volume":"5","author":"Wang L","year":"2023","unstructured":"Wang L, Zhang Z, Wang D, et al.. Human-centered design and evaluation of AI-empowered clinical decision support systems: a systematic review. Front Comput Sci. 2023, 5:1187299. 10.3389\/fcomp.2023.1187299","journal-title":"Front Comput Sci"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.sciaf.2023.e01638","article-title":"Remote patient monitoring systems: applications, architecture, and challenges","volume":"20","author":"Boikanyo K","year":"2023","unstructured":"Boikanyo K, Zungeru AM, Sigweni B, Yahya A, Lebekwe C. Remote patient monitoring systems: applications, architecture, and challenges. Sci Afr. 2023, 20:e01638. 10.1016\/j.sciaf.2023.e01638","journal-title":"Sci Afr"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1093\/ehjdh\/ztad049","article-title":"Developing a personalized remote patient monitoring algorithm: a proof-of-concept in heart failure","volume":"4","author":"Moazeni M","year":"2023","unstructured":"Moazeni M, Numan L, Brons M, et al.. Developing a personalized remote patient monitoring algorithm: a proof-of-concept in heart failure. Eur Heart J Digit Health. 2023, 4:455-63. 10.1093\/ehjdh\/ztad049","journal-title":"Eur Heart J Digit Health"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3390\/s24123977","article-title":"Introducing a remote patient monitoring usability impact model to overcome challenges","volume":"24","author":"Baumann S","year":"2024","unstructured":"Baumann S, Stone RT, Abdelall E. Introducing a remote patient monitoring usability impact model to overcome challenges. Sensors (Basel). 2024, 24:3977. 10.3390\/s24123977","journal-title":"Sensors (Basel)"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02450-3","article-title":"Artificial intelligence in cancer: applications, challenges, and future perspectives","volume":"24","author":"Cheng CH","year":"2025","unstructured":"Cheng CH, Shi SS. Artificial intelligence in cancer: applications, challenges, and future perspectives. Mol Cancer. 2025, 24:274. 10.1186\/s12943-025-02450-3","journal-title":"Mol Cancer"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-020-00079-3","article-title":"Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy","volume":"6","author":"Kamphuis JA","year":"2020","unstructured":"Kamphuis JA, Linschoten M, Cramer MJ, Doevendans PA, Asselbergs FW, Teske AJ. Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy. Cardiooncology. 2020, 6:23. 10.1186\/s40959-020-00079-3","journal-title":"Cardiooncology"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-025-02215-w","article-title":"Artificial intelligence applications in cardio-oncology: a comprehensive review","volume":"27","author":"Guha A","year":"2025","unstructured":"Guha A, Shah V, Nahle T, et al.. Artificial intelligence applications in cardio-oncology: a comprehensive review. Curr Cardiol Rep. 2025, 27:56. 10.1007\/s11886-025-02215-w","journal-title":"Curr Cardiol Rep"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1161\/HCG.0000000000000097","article-title":"Artificial intelligence to enhance precision medicine in cardio-oncology: a scientific statement from the American Heart Association","volume":"18","author":"Khera R","year":"2025","unstructured":"Khera R, Asnani AH, Krive J, et al.. Artificial intelligence to enhance precision medicine in cardio-oncology: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2025, 18:e000097. 10.1161\/HCG.0000000000000097","journal-title":"Circ Genom Precis Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-024-01059-x","article-title":"The digital revolution in medicine: applications in cardio-oncology","volume":"27","author":"Echefu G","year":"2025","unstructured":"Echefu G, Batalik L, Lukan A, Shah R, Nain P, Guha A, Brown SA. The digital revolution in medicine: applications in cardio-oncology. Curr Treat Options Cardiovasc Med. 2025, 27:2. 10.1007\/s11936-024-01059-x","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-024-09866-1","article-title":"Assessment of native myocardial T1 mapping for early detection of anthracycline-induced cardiotoxicity in patients with cancer: a systematic review and meta-analysis","volume":"24","author":"Mohamed AA","year":"2024","unstructured":"Mohamed AA, Elmancy LY, Abulola SM, Al-Qattan SA, Mohamed Ibrahim MI, Maayah ZH. Assessment of native myocardial T1 mapping for early detection of anthracycline-induced cardiotoxicity in patients with cancer: a systematic review and meta-analysis. Cardiovasc Toxicol. 2024, 24:563-75. 10.1007\/s12012-024-09866-1","journal-title":"Cardiovasc Toxicol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)30037-6","article-title":"Reporting of artificial intelligence prediction models","volume":"393","author":"Collins GS","year":"2019","unstructured":"Collins GS, Moons KG. Reporting of artificial intelligence prediction models. Lancet. 2019, 393:1577-9. 10.1016\/s0140-6736(19)30037-6","journal-title":"Lancet"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1426-2","article-title":"Key challenges for delivering clinical impact with artificial intelligence","volume":"17","author":"Kelly CJ","year":"2019","unstructured":"Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019, 17:195. 10.1186\/s12916-019-1426-2","journal-title":"BMC Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/469371-early-detection-of-anthracycline-induced-cardiomyopathy-a-narrative-review-of-the-role-of-artificial-intelligence-and-remote-monitoring","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:40:05Z","timestamp":1782200405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/469371-early-detection-of-anthracycline-induced-cardiomyopathy-a-narrative-review-of-the-role-of-artificial-intelligence-and-remote-monitoring"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":71,"URL":"https:\/\/doi.org\/10.7759\/cureus.111338","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}